A chemical method for the labeling of fibrinogen with 99mTc
- PMID: 750207
- DOI: 10.1007/BF00251631
A chemical method for the labeling of fibrinogen with 99mTc
Abstract
A new method allowing the labelling of fibrinogen with 99mTcO4- is described. The 99mTcO4- is reduced by stannous chloride in an alkaline medium. After 1 h incubation with fibrinogen, the pH was brought down to 7.1. The study of (1) the pH of the solution, (2) the quantity of the reducer, and (3) the time of incubation allowed us to specify optimal conditions for labeling. The labeling yield varied from 91.68% plus or minus 6.05% to 95.18% plus or minus 2.13% according to the method of control used: the precipitation of fibrinogen by (NH4)2SO4 25% or thin-layer chromatography with methylethylketone as solvent. Clottable radioactivity averaged 72% plus or minus 4.43%. Column chromatography separated the tracer into two radioactive peaks. The first peak corresponded to the fibrinogen and carried 73.36% plus or minus 5.8% of the total radioactivity. The total recovered radioactivity amounted to 89.86% plus or minus 8.07%. Spectroscopic clottability was 88.23% plus or minus 2.42%. The in vivo stability of the labeling and the molecule was followed for 24 h after intravenous injection. If the radioactivity measured in the 5 min sample was considered to equal 100%, the 24 h sample averaged 32.71% plus or minus 3.25%, of which 85.68% plus or minus 2.92% was recovered in the clot. In conclusion, this method enabled us to obtain a stable tracer that we used for routine investigations in man.
Similar articles
-
Factors affecting the labeling of human fibrinogen with 99mTc in vitro.Int J Appl Radiat Isot. 1984 Feb;35(2):99-102. doi: 10.1016/0020-708x(84)90191-1. Int J Appl Radiat Isot. 1984. PMID: 6706430
-
Some chemical aspects of labeling human fibrinogen with 99m-technetium.Thromb Res. 1982 Nov 1;28(3):351-60. doi: 10.1016/0049-3848(82)90117-7. Thromb Res. 1982. PMID: 6294903
-
[99MTechnetium-fibrinogen labeling using electrolytic zircuronium release].Nucl Med (Stuttg). 1975 Jun 30;14(2):172-84. Nucl Med (Stuttg). 1975. PMID: 1178516 German.
-
Technetium-99m-human fibrinogen.J Nucl Med. 1975 May;16(5):343-7. J Nucl Med. 1975. PMID: 1194984
-
In vitro studies of leukocyte labeling with technetium-99m.J Nucl Med. 1976 Aug;17(8):730-6. J Nucl Med. 1976. PMID: 932819
Cited by
-
An experimental study of deep-vein thrombosis using 99mTc-fibrinogen.Eur J Nucl Med. 1984;9(12):548-52. doi: 10.1007/BF00256854. Eur J Nucl Med. 1984. PMID: 6526054
-
The interpretation of phlebograms using fibrinogen labeled with 99 mTc.Eur J Nucl Med. 1978;3(4):233-8. doi: 10.1007/BF00251398. Eur J Nucl Med. 1978. PMID: 720353
-
In vitro properties and in vivo behavior of technetium-99m labeled fibrinogens.Ann Nucl Med. 1996 Feb;10(1):63-9. doi: 10.1007/BF03165055. Ann Nucl Med. 1996. PMID: 8814729
-
67 Ga-labeled human fibrinogen: a new promising thrombus imaging agent.Eur J Nucl Med. 1982;7(10):458-61. doi: 10.1007/BF00253082. Eur J Nucl Med. 1982. PMID: 7140780
-
99mTc-fibrinogen as a thrombus-imaging agent.Eur J Nucl Med. 1978;3(4):267. doi: 10.1007/BF00251404. Eur J Nucl Med. 1978. PMID: 720357 No abstract available.
References
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources